Year | Volume (Price x Shares) | Change |
---|---|---|
2023 | $30.1 M | -88.75% |
2022 | $0.26 B | 97.85% |
2021 | $0.13 B | -41.09% |
2020 | $0.22 B | 93.47% |
2019 | $0.11 B | -83.14% |
2018 | $0.70 B | 537.75% |
2017 | $0.11 B | -73.45% |
2016 | $0.41 B | -10.96% |
2015 | $0.46 B | -44.68% |
2014 | $0.84 B | 249.24% |
2013 | $0.24 B |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $66.53 M | $0.31 B | ๐บ๐ธ USA |
![]() Pfizer PFE | $0.23 B | $0.56 B | ๐บ๐ธ USA |
![]() AbbVie ABBV | $0.13 B | $0.43 B | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $42.87 M | $0.29 B | ๐บ๐ธ USA |
![]() Amgen AMGN | $81.07 M | $0.51 B | ๐บ๐ธ USA |
![]() Biogen BIIB | $8.79 M | $65.55 M | ๐บ๐ธ USA |
![]() Illumina ILMN | $3.47 M | $50.24 M | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | $45.72 M | $0.18 B | ๐บ๐ธ USA |
![]() Merck MRK | $0.24 B | $0.58 B | ๐บ๐ธ USA |